Vaccines

16 Aug 2017 VBI Vaccines Announces FDA Acceptance of Investigational New Drug Application for VBI-1901 to Treat Glioblastoma Multiforme
11 Aug 2017 Immunicum AB (publ) Announces Enrollment of First United States Patient in the Ongoing Phase 2 MERECA Trial for Ilixadencel
02 Aug 2017 Madison Vaccines Announces First Patient Dosed in an Expanded Combination Trial of MVI-816 Plus Keytruda® for Metastatic, Treatment-Resistant Prostate Cancer
01 Aug 2017 Dynavax Announces FDA Advisory Committee Vote in Favor of HEPLISAV-B
29 Jul 2017 VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine
27 Jul 2017 Chikungunya-fever: Themis Bioscience starts phase II clinical study in endemic area
27 Jul 2017 CureVac Announces Publication in The Lancet of First-Ever Human Proof-of-Concept Study Investigating the Safety and Immunogenicity of a Prophylactic mRNA Vaccine
27 Jul 2017 Emergent BioSolutions Secures Exclusive Worldwide Rights to Valneva’s Zika Vaccine Technology
25 Jul 2017 Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs
24 Jul 2017 Genocea Reports Positive Top-Line 12-Month Phase 2b Data for GEN-003 in Genital Herpes
24 Jul 2017 Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine
24 Jul 2017 VALNEVA Receives FDA Fast Track Designation for its Lyme Disease Vaccine Candidate VLA15
20 Jul 2017 BriaCell Provides Clinical Update on its Ongoing Phase I/IIa Clinical Study of BriaVaxTM in Advanced Breast Cancer
19 Jul 2017 Biothera Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Study Evaluating Combination of Imprime PGG and Merck’s KEYTRUDA in Non-Small Cell Lung Cancer
18 Jul 2017 AXON's Tau Vaccine Has Completed Phase II Enrolment in Alzheimer's
14 Jul 2017 Publication in Cell Demonstrates Moderna’s Zika mRNA Vaccine Prevents In Utero Transmission of Zika Virus in Mice, Protects Against Zika-Related Congenital Damage
12 Jul 2017 Meissa Vaccines awarded $1.6m Fast Track SBIR Grant to advance IND preparations for RSV vaccine candidate
06 Jul 2017 Nature Publication Reports Favorable Clinical Trial Results of BioNTech’s Individualized Cancer Vaccine IVAC® MUTANOME
06 Jul 2017 Initial Results from Dana-Farber Cancer Institute Personalized Neoantigen Vaccine Published in Nature
05 Jul 2017 Aimmune Therapeutics Enrolls First Patient in ARTEMIS (ARC010) European Phase 3 Clinical Trial of AR101 for the Treatment of Peanut Allergy
30 Jun 2017 ALK: Five-year GRAZAX® Asthma Prevention (GAP) Trial Reveals Benefits of Early Treatment Intervention in Children
27 Jun 2017 Araclon Biotech initiates phase II clinical trials of its Alzheimer's vaccine
27 Jun 2017 GSK receives CHMP positive opinion for Synflorix pneumococcal vaccine four-dose vial
27 Jun 2017 OSE Immunotherapeutics Announces Temporary Pause of Patient Accrual While Continuing Treatment for Patients Already Enrolled In Phase 3 Clinical Trial of Tedopi® in Advanced Lung Cancer
21 Jun 2017 ImmunoCellular Therapeutics Provides Update on Strategic Review and Decision to Suspend Further Patient Randomization for ICT-107 Phase 3 Trial

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top